COMMUNIQUÉS West-GlobeNewswire

Equillium Granted U.S. FDA Fast Track Designation for EQ001 for the Treatment of Acute Graft-Versus-Host Disease
19/12/2018
Company plans to initiate Phase 1b/2 EQUATE clinical trial in early 2019 LA JOLLA, Calif., Dec. 19, 2018 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a biotechnology company developing treatments for severe immuno- [...]
Evolus Added to NASDAQ Biotechnology Index
19/12/2018
IRVINE, Calif., Dec. 19, 2018 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a company dedicated to aesthetic medicine, today announced that the company has been selected for addition to the NASDAQ Biotechnology Index [...]
Spectral to Attend the 37th Annual J.P. Morgan Healthcare Conference
19/12/2018
TORONTO, Dec. 19, 2018 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX:EDT) , a Phase III company developing the first treatment for patients with endotoxemic septic shock guided by a [...]
Nemaura to Host Investor Webinar on December 21 to Provide Update on Recent Developments
19/12/2018
LOUGHBOROUGH, England - Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing sugarBEAT® as a non-invasive, affordable and flexible Continuous Glucose Monitor (CGM) for use by people with diabetes [...]
Krystal Biotech Completes Dosing in the GEM-Phase 2 Study in Pediatric Patients for the Treatment of Dystrophic Epidermolysis Bullosa
19/12/2018
Top line results from GEM-Phase 2 study expected in H1 2019 PITTSBURGH, Dec. 19, 2018 (GLOBE NEWSWIRE) -- Krystal Biotech Inc. , (“Krystal”) (NASDAQ: KRYS), a gene therapy company developing topical and intradermal "off [...]
AMAG Pharmaceuticals to Present at the 37th Annual J.P. Morgan Healthcare Conference
19/12/2018
WALTHAM, Mass., Dec. 19, 2018 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that William Heiden, president and chief executive officer, will present at the 37 th Annual J.P. Morgan [...]
Johnson & Johnson's Biosense Webster’s MaryAnn Edzards Joins BioSig
19/12/2018
Former New Technology Education Manager to Assist with First Installations Santa Monica, CA, Dec. 19, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a [...]
resTORbio Appoints William Marshall, M.D., as Vice President of Medical Sciences
19/12/2018
BOSTON, Dec. 19, 2018 (GLOBE NEWSWIRE) -- resTORbio, Inc. (Nasdaq:TORC), a clinical-stage biopharmaceutical company focused on helping people live healthier longer through the development and commercialization of novel [...]
RTI Donor Services and Versiti Celebrate the Gift of Tissue Donation with Donate Life Float in 2019 Rose Parade®
19/12/2018
RTI Donor Services sponsors tissue recipient as walker on float MILWAUKEE, Dec. 19, 2018 (GLOBE NEWSWIRE) -- RTI Donor Services (RTIDS), a nonprofit organization dedicated to providing responsible stewardship of the [...]
Allogene Therapeutics to Present at the 37th Annual J.P. Morgan Healthcare Conference
19/12/2018
SOUTH SAN FRANCISCO, Calif., Dec. 19, 2018 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) therapies for [...]
Immunomedics To Present at the 37th Annual J.P. Morgan Healthcare Conference
19/12/2018
MORRIS PLAINS, N.J., Dec. 19, 2018 (GLOBE NEWSWIRE) -- Immunomedics, Inc. , (NASDAQ: IMMU) (“Immunomedics” or the “Company”), a leading biopharmaceutical company in the area of antibody-drug conjugates, today announced [...]
Avenue Therapeutics Announces Dosing of First Patient in Second Pivotal Phase 3 Clinical Trial of Intravenous Tramadol for the Management of Postoperative Pain
19/12/2018
Topline data readout expected in mid-2019 NEW YORK, Dec. 19, 2018 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (NASDAQ: ATXI) (“Avenue”), a specialty pharmaceutical company focused on the development and [...]
CardioDx Presents Comparative Effectiveness Claims Analysis Highlighting the Clinical Value of the Corus® CAD Precision Medicine Blood Test in Elderly Patients at the Gerontological Society of America 2018 Annual Meeting
19/12/2018
Corus CAD Blood Test Was Associated With Decreased Downstream CAD-Related Healthcare Utilization in the Real-World Study of Elderly Patients Evaluated for Suspected Coronary Artery Disease REDWOOD CITY, Calif., Dec. 19 [...]
Avalon GloboCare to Ring the Nasdaq Stock Market Closing Bell on January 7, 2019 at 4:00 PM Eastern
19/12/2018
FREEHOLD, N.J., Dec. 19, 2018 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (NASDAQ: AVCO), a leading global developer of cell-based technologies and therapeutics, today announced that it will ring The Nasdaq Stock Market [...]
AzurRx BioPharma Announces Initiation of Phase II OPTION Clinical Trial of MS1819-SD in Cystic Fibrosis Patients
19/12/2018
First site initiated at the Cystic Fibrosis Institute Initial top line data expected in 2019 NEW YORK, Dec. 19, 2018 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ:AZRX) (“AzurRx” or the “Company”), a company [...]
KemPharm Provides Corporate Update on Partnering Process for ADHD Prodrug Portfolio
19/12/2018
CELEBRATION, Fla., Dec. 19, 2018 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NASDAQ: KMPH), a specialty pharmaceutical company engaged in the discovery and development of proprietary prodrugs, today provided a corporate update [...]
Strongbridge Biopharma plc Announces Closing of Transaction with Novo Nordisk to Transfer the Rights to MACRILEN™ (macimorelin) in the United States and Canada
19/12/2018
Strongbridge Used Portion of $145 Million Upfront Cash Payment from Novo Nordisk to Fully Repay Outstanding Debt DUBLIN, Ireland and TREVOSE, Pa., Dec. 19, 2018 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq: [...]
Radient Technologies Inc. Files Provisional Applications for Innovating Cannabinoid-Infused Food & Beverage Manufacturing Processes
19/12/2018
EDMONTON, Alberta, Dec. 19, 2018 (GLOBE NEWSWIRE) -- Radient Technologies Inc. (“Radient” or the “Company”) ( TSX Venture: RTI; OTCQX: RDDTF ) is pleased to announce that it has now filed an additional 9 provisional [...]
Mesoblast Makes Executive Appointment to Drive Product Commercialization
19/12/2018
NEW YORK and MELBOURNE, Australia, Dec. 19, 2018 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB) today announced that it has appointed Eric Strati, PhD, to the new position of Senior Vice President, [...]

Pages